Dana-Farber scientists present promising findings in multiple myeloma at ASH Annual Meeting

(Dana-Farber Cancer Institute) Results of studies on a novel agent to treat multiple myeloma and a combination therapy aimed at slowing the progression of a precursor myeloma condition are among reports being presented by Dana-Farber Cancer Institute investigators at the ASH Annual Meeting.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news